Replies to post #799072 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

There has to already be C suites owned by other companies so once approved and installed in Sawston what's to stop renting space elsewhere and slapping in a few Flaskworks units and have Advent employees produce DCVax-l in different locations. I think LP hinted something like that recently about setting up agreements at various hospitals. They could ramp up the production volume of DCVax rapidly.

I agree that Flaskworks units can be upscaled relatively easily (especially compared to manual) and yes raidly.
I think NWBO had no choice and did the right thing, alas, longs have to wait longer than anticipated.